
|Articles|June 14, 2007
ADHD pharmacotherapy: Prescribe with safety in mind and monitor results with vigilance
The keys to optimal use of psychostimulant and nonstimulant medications for attention deficit hyperactivity disorder are careful screening of patients, appropriate dosage regulation, and?most of all?close monitoring of both positive and adverse outcomes.
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Olivia Kim-McManus, MD, discusses genetic testing, therapy in pediatric neurology
2
FDA expands antithrombin III (human) label to pediatric patients with rare blood-clotting disorder
3
FDA accepts roflumilast cream 0.3% sNDA to treat plaque psoriasis in children 2 to 5 years
4
Roflumilast Efficacy and Safety in Pediatric AD
5













